Please login to the form below

Not currently logged in
Email:
Password:

anti-CD3 mAb

This page shows the latest anti-CD3 mAb news and features for those working in and with pharma, biotech and healthcare.

Tiziana joins type 1 diabetes prevention field

Tiziana joins type 1 diabetes prevention field

Teplizumab is a mouse derived anti-CD3 mAb, and is administered intravenously. ... Now Tiziana is looking to rival Provention with the development of its own anti-CD3 mAB foralumab, which it says is the only entirely human anti-CD3 mAb.

Latest news

  • The impact of insulin

    Monoclonal antibodies. Tolerx and GSK are developing otelixizumab, an intravenous anti-CD3 humanised version of the monoclonal antibody (mAb) YTH-12.5. ... The US Juvenile Diabetes Research Foundation (JDRF) has provided $2m funding for a pivotal,

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics